| Views | |
|---|---|
| Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies | 596 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies | 8 | 3 | 11 | 6 | 25 | 23 | 2 |
| Views | |
|---|---|
| Dissertation_P.Mehlitz_2016.pdf | 370 |
